Technology

Selective Cox-2 Inhibitors Market – Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of Selective Cox-2 Inhibitors in Global, including the following market information:

  • Global Selective Cox-2 Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global top five companies in 2021 (%)

 

The global Selective Cox-2 Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Meloxicam Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Selective Cox-2 Inhibitors include Boehringer-Ingelheim, TerSera Therapeutics, Iroko Pharmaceuticals, Apotex, Yung Shin Pharmaceutical, Breckenridge Pharmaceutical, Meda Pharmaceuticals, Cipla and Glenmark Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Selective Cox-2 Inhibitors companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Selective Cox-2 Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Selective Cox-2 Inhibitors Market Segment Percentages, by Type, 2021 (%)

  • Meloxicam
  • Celecoxib
  • Etoricoxib
  • Imrecoxib
  • Etodolac
  • Parecoxib
  • Other

Global Selective Cox-2 Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Selective Cox-2 Inhibitors Market Segment Percentages, by Application, 2021 (%)

  • Rheumatoid Arthritis
  • Osteoarthritis
  • Spondylosis Chronica Ankylopoietica
  • Other

Global Selective Cox-2 Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Selective Cox-2 Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Selective Cox-2 Inhibitors revenues in global market, 2017-2022 (estimated), ($ millions)
  • Key companies Selective Cox-2 Inhibitors revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • Boehringer-Ingelheim
  • TerSera Therapeutics
  • Iroko Pharmaceuticals
  • Apotex
  • Yung Shin Pharmaceutical
  • Breckenridge Pharmaceutical
  • Meda Pharmaceuticals
  • Cipla
  • Glenmark Pharmaceuticals
  • Teva
  • PuraCap Pharmaceutical
  • Almirall Limited
  • Lupin Pharmaceuticals
  • Aurobindo Pharma
  • Pfizer
  • Mylan
  • Takeda
  • Bayer
  • Novacap
  • Abbott
  • Geri-Care
  • Perrigo
  • Kopran
  • Merck
  • Hengrui pharmaceutical
  • Kelun Group
  • Qilu Pharmaceutical
  • Taro Pharmaceuticals

Table of content

1 Introduction to Research & Analysis Reports
1.1 Selective Cox-2 Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Selective Cox-2 Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Selective Cox-2 Inhibitors Overall Market Size
2.1 Global Selective Cox-2 Inhibitors Market Size: 2021 VS 2028
2.2 Global Selective Cox-2 Inhibitors Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Selective Cox-2 Inhibitors Players in Global Market
3.2 Top Global Selective Cox-2 Inhibitors Companies Ranked by Revenue
3.3 Global Selective Cox-2 Inhibitors Revenue by Companies
3.4 Top 3 and Top 5 Selective Cox-2 Inhibitors Companies in Global Market, by Revenue in 2021
3.5 Global Companies Selective Cox-2 Inhibitors Product Type
3.6 Tier 1, Tier 2 and Tier 3 Selective Cox-2 Inhibitors Players in Global Market
3.6.1 List of Global Tier 1 Selective Cox-2 Inhibitors Companies
3.6.2 List of Global Tier 2 and Tier 3 Selective Cox-2 Inhibitors Companies

CONTACT US:
276 5th Avenue, New York, NY 10001, United States
International: +1(646)-781-7170 / +91 8087042414

Similar Reports:

Global and China Selective Cox-2 Inhibitors Market Size, Status and Forecast 2021-2027

Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Status and Forecast 2021-2027

Global Selective Cox-2 Inhibitors Market Size, Status and Forecast 2021-2027

COVID-19 Impact on Global Selective Serotonin Reuptake Inhibitors (SSRIs) Market Size, Status and Forecast 2020-2026

Related Articles

Back to top button